These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2758562)
21. A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma. Bower M; Brock C; Gulliford T; O'Reilly SM; Smith DB; Newlands ES Cancer Chemother Pharmacol; 1996; 38(1):106-9. PubMed ID: 8603443 [TBL] [Abstract][Full Text] [Related]
22. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764 [TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study. Rödel S; Engert A; Diehl V; Reiser M Leuk Lymphoma; 2005 Dec; 46(12):1729-34. PubMed ID: 16353313 [TBL] [Abstract][Full Text] [Related]
24. EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas. Smith DB; Ledermann JA; Boesen E; Newlands ES; Begent RH; Rustin GJ; Glaser MG; Bagshawe KD Eur J Cancer Clin Oncol; 1989 Jun; 25(6):991-4. PubMed ID: 2753060 [TBL] [Abstract][Full Text] [Related]
25. The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma. Dreiher J; Shpilberg O; Raanani P; Chetrit A; Ben-Bassat I Leuk Res; 1998 Nov; 22(11):997-1002. PubMed ID: 9783801 [TBL] [Abstract][Full Text] [Related]
26. Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP. Steinke B; Bross K; Reinold HM; Heim ME; Schalk KP; Heidemann E; Josten K; Arnold H; Manegold C; Hoffman I Eur J Cancer; 1992; 28(1):100-4. PubMed ID: 1373634 [TBL] [Abstract][Full Text] [Related]
35. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814 [TBL] [Abstract][Full Text] [Related]
36. EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma. Somers R; Carde P; Thomas J; Tirelli U; Keuning JJ; Bron D; Delmer A; de Bock R; De Wolf-Peeters C; Keunig JJ Ann Oncol; 1994; 5 Suppl 2():85-9. PubMed ID: 7515651 [TBL] [Abstract][Full Text] [Related]
38. Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM). Battista C; Panza N; Chiurazzi B; Iodice G; Esposito G; Cocorocchio E; Bevilacqua N; Pacilio G Biomed Pharmacother; 1993; 47(4):145-54. PubMed ID: 8018826 [TBL] [Abstract][Full Text] [Related]
39. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin's lymphoma. Shimizu K; Hara K; Kunii A Am J Clin Oncol; 1989 Jun; 12(3):195-200. PubMed ID: 2729176 [TBL] [Abstract][Full Text] [Related]
40. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma]. Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]